AKT1 and hypertrophic cardiomyopathy: Six enriched KEGG pathways (Figure 6A and Table S2) were recorded: phosphatidylinositol-3 kinase (PI3K)-Akt signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, arrhythmogenic right ventricular cardiomyopathy (ARVC), hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and extracellular matrix (ECM)–receptor interaction.